Targeting SMC3 deacetylation synergizes with XPO1 inhibition to reprogram the epigenetic landscape and suppress NPM1-mutated acute myeloid leukemia

Jianfeng Fu, Huilin Xu, Xinying Zhao, Mengge Gao, Yonglu Tian, Yingjun Chang, Xiaofeng Zheng · 2026

Read Targeting SMC3 deacetylation synergizes with XPO1 inhibition to reprogram the epigenetic landscape and suppress NPM1-mutated acute myeloid leukemia by Jianfeng Fu, Huilin Xu, Xinying Zhao, Mengge Gao, Yonglu Tian, Yingjun Chang, Xiaofeng Zheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13408497.txt.

Description

Jianfeng Fu and co-authors present a 2026 study of a drug pair for a common form of acute myeloid leukemia. This blood cancer often carries faults in one gene, NPM1, whose control wiring was murky. A DNA folding complex, tuned by marks on one of its parts, helps run gene activity in these cells.

Loss of the enzyme that places those marks loosened the complex and freed self renewal genes. A drug that blocks the mark removing enzyme restored the grip and pushed cells to mature or die. Adding a second drug that blocks a nuclear export protein deepened the reset. The pair wiped out leukemia lines and patient cells in dishes and in mice. The authors propose the pair for trials.

Catalog record

CREATORJianfeng Fu, Huilin Xu, Xinying Zhao, Mengge Gao, Yonglu Tian, Yingjun Chang, Xiaofeng Zheng
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE84 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13408497

Browse the full library · About the Tower of Babel